Rx-Only Pseudoephedrine Stalls As Meth Solution In Tennessee, Indiana
This article was originally published in The Tan Sheet
Executive Summary
Tennessee’s meth lab seizures are up this year, but CHPA says that’s because more labs are uncovered through the state’s participation in the NPLEx stop-sale system. Rx-only bills have stalled in several states, including Indiana, where lawmakers passed a bill to cap PSE purchases at about 61 grams per year.
You may also be interested in...
To Curb PSE Diversion, Retailers Lead By Example With Emphasis On Tamper-Resistant Products
An HHS agency’s 2013 drug use survey shows the number of meth users rising by 155,000 after changing little the previous two years. Acura Pharmaceuticals notes the survey and Tennessee data showing that making only tamper-resistant, single-ingredient PSE products available affects the diversion rate.
To Curb PSE Diversion, Retailers Lead By Example With Emphasis On Tamper-Resistant Products
An HHS agency’s 2013 drug use survey shows the number of meth users rising by 155,000 after changing little the previous two years. Acura Pharmaceuticals notes the survey and Tennessee data showing that making only tamper-resistant, single-ingredient PSE products available affects the diversion rate.
Tennessee AG Challenges Local PSE Prescription Laws
Tennessee AG Robert Cooper pushes back against local ordinances to require prescriptions for pseudoephedrine. Acura Pharmaceuticals says stricter local laws could block potential extraction-resistant products from OTC sale.